Tag : III

Latest News

FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s...
Latest News

Global Research Nonprofit CureDuchenne Joins Pfizer to Host Free Webinar on Pfizer’s Advancement to Phase III Gene Therapy Clinical Trial

Newsemia
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne, the leading global nonprofit focused on finding a cure for Duchenne muscular dystrophy, will co-host a free webinar with Pfizer to...
Latest News

Species conservation profiles of a random sample of world spiders III: Oecobiidae to Salticidae

Newsemia
Seppälä, S; Henriques, S; Draney, ML; Foord, S; Gibbons, AT; Gomez, LA; Kariko, S; … Cardoso, P; + view all Seppälä, S; Henriques, S; Draney,...
Latest News

Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design

Newsemia
Moreau, P; Dimopoulos, MA; Yong, K; Mikhael, J; Risse, M-L; Asset, G; Martin, T; (2020) Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple...
Latest News

Antithrombin III Testing Market, 2020 – Competitive Strategies, Country Forecasts, Innovative technologies & Instrumentation – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “2020 Antithrombin III Testing Market: USA, Europe, Japan – Competitive Strategies, Country Forecasts, Innovative technologies and Instrumentation” report has been added to ResearchAndMarkets.com’s...
Latest News

Study of the spatial association between an active region jet and a nonthermal type III radio burst

Newsemia
Mulay, SM; Sharma, R; Valori, G; Vasquez, AM; Del Zanna, G; Mason, H; Oberoi, D; (2019) Study of the spatial association between an active region...
Surgery/Cosmetic

Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy – A systematic review and meta-analysis

Newsemia
There has been an increasing interest in the complete pathological response (pCR) in rectal cancers following neoadjuvant therapy. The aim of this study was to...
Latest News

Samenvatting: Resultaten van Fase III SAkuraSky-studie voor Chugai’s Satralizumab bij Neuromyelitis Optica Spectrumstoornis Gepubliceerd in The New England Journal of Medicine Online

Newsemia
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) heeft aangekondigd dat de resultaten van de SAkuraSky-studie (NCT02028884), een wereldwijde fase III klinische studie van satralizumab (ontwikkelingscode:...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy